Discontinuation report RITALIN-SR TAB 20MG
Report ID | 154439 |
Drug Identification Number | 00632775 |
Brand name | RITALIN-SR TAB 20MG |
Common or Proper name | RITALIN SR 20MG 100'S |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100'S |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-03-31 |
Actual discontinuation date | 2022-04-01 |
Remaining supply date | 2022-09-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-04-05 | French | Compare |
v5 | 2022-04-05 | English | Compare |
v4 | 2022-03-30 | French | Compare |
v3 | 2022-03-30 | English | Compare |
v2 | 2022-02-08 | French | Compare |
v1 | 2022-02-08 | English | Compare |
Showing 1 to 6 of 6